Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Methotrexate|DRUG: Fluorouracil implant|DRUG: Goserelin|DRUG: Tamoxifen
Sponsor: Austrian Breast & Colorectal Cancer Study Group
Collaborators: AstraZeneca